About Bridge-like lipid transfer protein family member 3B
Bridge-like lipid transfer protein family member 3B (BLTP3B) is a protein
from Homo sapiens identified by UniProt accession
A0JNW5, 1464 residues long.
MolForge cross-references it against 0 known binders and
14 disease associations.
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
Disease associations (14)
Diseases linked to this target (Open Targets).
- gut microbiome measurement · score 0.33
- cardiovascular disease · score 0.10
- isolated asymptomatic elevation of creatine phosphokinase · score 0.07
- pentosuria · score 0.05
- adolescent idiopathic scoliosis · score 0.04
- total blood protein measurement · score 0.04
- insomnia · score 0.04
- Plasmodium falciparum malaria · score 0.01
- chronic kidney disease · score 0.00
- Parkinson disease · score 0.00
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
Experimental structures are not indexed in MolForge yet —
search RCSB PDB for A0JNW5.
Amino-acid sequence (1464 residues)
MAGIIKKQIL KHLSRFTKNL SPDKINLSTL KGEGELKNLE LDEEVLQNML DLPTWLAINK VFCNKASIRI PWTKLKTHPI CLSLDKVIME MSTCEEPRSP NGPSPIATAS GQSEYGFAEK VVEGISVSVN SIVIRIGAKA FNASFELSQL RIYSVNAHWE HGDLRFTRIQ DPQRGEVLTF KEINWQMIRI EADATQSSHL EIMCAPVRLI TNQSKIRVTL KRRLKDCNVI ATKLVLILDD LLWVLTDSQL KAMVQYAKSL SEAIEKSTEQ RKSMAPEPTQ SSTVVASAQQ VKTTQTSNAP DVNDAIVKLF NDFDVKETSH HLVISHLDLH ICDDIHAKEK ESNRRITGGA MQLSFTQLTI DYYPYHKAGD SCNHWMYFSD ATKTKNGWAN ELLHEFECNV EMLKQAVKDH NVGSPPKSPT HASPQHTQTE KDYPLKGTCR TPSVLSQQSK AKLMSSSVVV RLADFNIYQV STAEQCRSSP KSMICCNKKS LYLPQEMSAV YIEFTEYYYP DGKDFPIPSP NLYSQLNALQ FTVDERSILW LNQFLLDLKQ SLNQFMAVYK LNDNSKSDEH VDVRVDGLML KFVIPSEVKS ECHQDQPRAI SIQSSEMIAT NTRHCPNCRH SDLEALFQDF KDCDFFSKTY TSFPKSCDNF NLLHPIFQRH AHEQDTKMHE IYKGNITPQL NKNTLKTSAA TDVWAVYFSQ FWIDYEGMKS GKGRPISFVD SFPLSIWICQ PTRYAESQKE PQTCNQVSLN TSQSESSDLA GRLKRKKLLK EYYSTESEPL TNGGQKPSSS DTFFRFSPSS SEADIHLLVH VHKHVSMQIN HYQYLLLLFL HESLILLSEN LRKDVEAVTG SPASQTSICI GILLRSAELA LLLHPVDQAN TLKSPVSESV SPVVPDYLPT ENGDFLSSKR KQISRDINRI RSVTVNHMSD NRSMSVDLSH IPLKDPLLFK SASDTNLQKG ISFMDYLSDK HLGKISEDES SGLVYKSGSG EIGSETSDKK DSFYTDSSSI LNYREDSNIL SFDSDGNQNI LSSTLTSKGN ETIESIFKAE DLLPEAASLS ENLDISKEET PPVRTLKSQS SLSGKPKERC PPNLAPLCVS YKNMKRSSSQ MSLDTISLDS MILEEQLLES DGSDSHMFLE KGNKKNSTTN YRGTAESVNA GANLQNYGET SPDAISTNSE GAQENHDDLM SVVVFKITGV NGEIDIRGED TEICLQVNQV TPDQLGNISL RHYLCNRPVG SDQKAVIHSK SSPEISLRFE SGPGAVIHSL LAEKNGFLQC HIENFSTEFL TSSLMNIQHF LEDETVATVM PMKIQVSNTK INLKDDSPRS STVSLEPAPV TVHIDHLVVE RSDDGSFHIR DSHMLNTGND LKENVKSDSV LLTSGKYDLK KQRSVTQATQ TSPGVPWPSQ SANFPEFSFD FTREQLMEEN ESLKQELAKA KMALAEAHLE KDALLHHIKK MTVE
Explore Bridge-like lipid transfer protein family member 3B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets